Back to Exihibitor List
Register as primary visitor list
Registered
5B-21【特設】ジェンダード・イノベーションEXPO
Craif Inc.
Cancer risk testing that can be done at home on two axes: "for life" and "now".
miSignal® can help those who have recently become concerned about cancer or who are already undergoing regular cancer screening. 2 tests detect your natural disposition and current cancer risk, including pancreatic cancer, and 7 cancer risks from stage 1 by cancer type. In the event that the risk is high, we will provide you with specific recommendations on what additional tests you should undergo at what department of the hospital.
Examples of products on display
miSignal Scan
・Evaluates the risk of up to 7 types of cancer individually with a single urine collection at home
・Higher detection sensitivity than conventional methods
・Possible early detection of pancreatic cancer, ovarian cancer, and other cancers that are not covered by the Cancer Screening Countermeasure Health Examination.
・Provides appropriate next steps
＞Click here for product information
["03","04","05"]
miSignal Navi
miSignal Navi is a genetic test that examines cancer susceptibility in seven cancer types. This is a once-in-a-lifetime test to find out where cancer is likely to occur constitutionally. This easy-to-use test uses next-generation technology to analyze genes in bodily fluids. The test provides you with cancer countermeasures for each of the seven cancer types, including cancers that you should be particularly concerned about in the future and ways to improve your lifestyle.
＞Click here for product information
["03","04","05"]
Keyword / Highlight
| ["13","25","26","29","30","31"] | |
Exhibitor information
| Company | Craif Inc. |
| Country | Japan |
| Address | 2-25-7 Yushima, Bunkyo-ku, Tokyo, 113-0034, Japan5F ITP Hongo Office |
| TEL | 03-6801-8334 |
| WEB | https://craif.com/ |
